Dyadic International enter distribution partnership with IBT Bioservices

Dyadic Applied BioSolutions entered into an original equipment manufacturer distribution agreement with Integrated Biotherapeutics, LLC, d/b/a IBT Bioservices. Through this collaboration, Dyadic-produced recombinant protein products will be commercialized through IBT’s established sales channels, expanding market access and supporting Dyadic’s objective of generating ongoing, product-based revenues. The initial products expected to be offered under the agreement include recombinant DNase I and recombinant transferrin, with a focus on research-use-only applications. Dyadic expects to offer both human and bovine transferrin, along with additional cell culture-relevant recombinant proteins, as part of a broader and expanding product portfolio.